|本期目录/Table of Contents|

[1]孟繁杰 综述,王广舜 审校.胸腺瘤与自身免疫性疾病的研究进展[J].天津医科大学学报,2021,27(02):195-198.
点击复制

胸腺瘤与自身免疫性疾病的研究进展(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27
期数:
2021年02期
页码:
195-198
栏目:
综述
出版日期:
2021-03-15

文章信息/Info

Title:
-
文章编号:
1006-8147(2021)02-0195-04
作者:
孟繁杰1 综述王广舜2 审校
(1.天津医科大学第二医院胸外科,天津300211;2.天津市宝坻区人民医院胸外科,天津301800)
Author(s):
-
关键词:
胸腺瘤自身免疫疾病重症肌无力系统性红斑狼疮
Keywords:
-
分类号:
R736.3
DOI:
-
文献标志码:
A
摘要:
胸腺瘤常伴发自身免疫性疾病,对人类健康产生不可忽视的影响。胸腺瘤患者伴发的自身免疫性疾病包括:重症肌无力(MG)、系统性红斑狼疮(SLE)、自身免疫性红细胞减少症、炎症性肌病、自身免疫性甲状腺功能减退症、自身免疫性肝炎、Good′s综合征(GS)、其他自身免疫性血细胞减少症等。目前,手术仍然是胸腺瘤的主要治疗手段,部分符合指征的患者也适用于免疫抑制及免疫球蛋白替代治疗。
Abstract:
-

参考文献/References:

[1] Garibaldi M,Fionda L,Vanoli F,et al. Muscle involvement in myasthenia gravis:expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients[J]. Autoimmun Rev,2020,19(4):102498
[2] Engels E A. Epidemiology of thymoma and associated malignancies[J]. J Thorac Oncol,2010,5(10 Suppl 4):S260
[3] Meurgey A,Girard N,Merveilleux du Vignaux C,et al. Assessment of the ITMIG statement on the WHO histological classification and of the eighth TNM staging of thymic epithelial tumors of a series of 188 thymic epithelial tumors[J]. J Thorac Oncol,2017,12(10):1571
[4] Padda SK,Yao X,Antonicelli A,et al. Paraneoplastic syndromes and thymic malignancies:an examination of the International Thymic Malignancy Interest Group retrospective database[J]. J Thorac Oncol,2018,13(3):436
[5] Guo R,erickson L A. Thymoma[J]. Mayo Clin Proc,2019,94(6):1122
[6] Merveilleux du Vignaux C,Dansin E,Mhanna L,et al. Systemic therapy in advanced thymic epithelial tumors:insights from the RYTHMIC prospective cohort[J]. J Thorac Oncol,2018,13(11):1762
[7] Hwang Y,Kang C H,Park S,et al. Impact of lymph node dissection on thymic malignancies:multi-institutional propensity score matched analysis[J]. J Thorac Oncol,2018,13(12):1949
[8] Gbolahan O B,Porter R F,Salter J T,et al. A phase Ⅱstudy of pemetrexed in patients with recurrent thymoma and thymic carcinoma[J]. J Thorac Oncol,2018,13(12):1940
[9] Jamilloux Y,Frih H,Bernard C,et al. Thymoma and autoimmune diseases[J]. Rev Med Interne,2018,39(1):17
[10] Hung C T,Tsai T F,Chen J S,et al. Thymoma-associated multiorgan autoimmunity[J]. BMJ Case Rep,2019,12(8):e229163
[11] Paranavitane S,Handagala S,De Silva R,et al. Thymoma complicated with myasthenia gravis and Good syndrome-a therapeutic conundrum: a case report[J]. J Med Case Rep,2019,13(1):348
[12] Yamada Y,Weis C A,Thelen J,et al. Thymoma associated Myasthenia Gravis(TAMG):differential expression of functional pathways in relation to MG status in different thymoma histotypes[J]. Front Immunol,2020,11:664
[13] Gilhus N E,Verschuuren J J. Myasthenia gravis: subgroup classification and therapeutic strategies[J]. Lancet Neurol,2015,14(10):1023
[14] Melzer N,Ruck T,Fuhr P,et al. Clinical features,pathogenesis,and treatment of myasthenia gravis: a supplement to the guidelines of the German neurological society[J]. J Neurol,2016,263(8):1473
[15] No?觕l N,Le Roy A,Hot A,et al. Systemic lupus erythematosus associated with thymoma:a fifteen-year observational study in France[J]. Autoimmun Rev,2020,19(3):102464
[16] Tomschik M,Hilger E,Rath J,et al. Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis[J]. Neurology,2020,19(4):102498
[17] Howard J F Jr,Utsugisawa K,Benatar M,et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis(REGAIN):a phase 3,randomised,double-blind,placebo-controlled,multicentre study[J]. Lancet Neurol,2017,16(12):976
[18] Mollaeian A,Haas C. A tale of autoimmunity:thymoma,thymectomy,and systemic lupus erythematosus[J]. Clin Rheumatol,2020,39(7):2227
[19] Panarese A,D′Andrea V,Pironi D,et al. Thymectomy and systemic lupus erythematosus (SLE)[J]. Ann Ital Chir,2014,85(6):617
[20] Gunes G,Malkan U Y,Yasar H A,et al. Clinicopathological associations of acquired erythroblastopenia[J]. Int J Clin Exp Med,2015, 8(12): 22515
[21] Lo Iacono G,Gigli F,Gherzi L,et al. Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis:a rare and life-treating condition[J]. Transfus Apher Sci,2020,59(2):102656
[22] Duarte Rodrigues B C,Freire P,Campos B,et al. Severe aplastic anemia developed after thymectomy: a case report and literature review[J]. Case Rep Hematol,2020,2020:7819321
[23] Hirokawa M,Sawada K,Fujishima N,et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group[J]. Haematologica,2008,93(1):27
[24] Souadjian J V,Enriquez P,Silverstein M N,et al. The spectrum of diseases associated with thymoma. Coincidence or syndrome?[J]. Arch Intern Med,1974,134(2):374
[25] Rini B I,Gajewski T F. Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide[J]. Ann Oncol,1999,10(8):973
[26] Aguirre F,Villa A M. Myasthenia gravis. register of 190 cases in a single center[J]. Medicina (B Aires),2020,80(1):10
[27] Chen Y L,Yeh J H,Chiu H C. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan[J]. Acta Neurol Scand,2013,127(3):170
[28] Stilwell K T,Musick S R,Cebe K M,et al. Thymoma-induced autoimmune hepatitis: a rare paraneoplastic syndrome[J]. Cureus,2019,11(9):e5637
[29] Nishimura T,Tsunezuka H,Miyata N,et al. Autoimmune hepatitis during preoperative chemotherapy in a patient with thymoma[J]. Interact Cardiovasc Thorac Surg,2019,29(4):635
[30] Kelesidis T,Yang O. Good′s syndrome remains a mystery after 55 years:a systematic review of the scientific evidence[J]. Clin Immunol,2010,135(3):347
[31] Malphettes M,Gérard L,Galicier L,et al. Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications[J]. Clin Infect Dis,2015,61(2):e13
[32] Levasseur P,Menestrier M,Gaud C,et al. Thymomas and associated diseases. Apropos of a series of 255 surgically treated thymomas[J]. Rev Mal Respir,1988,5(2):173
[33] Rivoisy C,Besse B,Girard N,et al. Thymic epithelial tumor-associated cytopenia: a 10-year observational study in France[J]. J Thorac Oncol,2016,11(3):391

相似文献/References:

[1]唐培源,戚 斌,陈 渊,等.shRNA干扰胸腺瘤细胞Wnt4基因后JNK基因表达下调[J].天津医科大学学报,2015,21(03):212.
 TANG Pei-yuan,QI Bin,CHEN Yuan,et al. Expression of JNK gene reduced by using shRNA interference Wnt4 gene in thymoma cells [J].Journal of Tianjin Medical University,2015,21(02):212.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金资助项目(81601411)
作者简介 孟繁杰(1987-),男,主治医师,硕士,研究方向:胸腺瘤与自身免疫疾病;通信作者:王广舜,E-mail: wgs@bddhospital.com。
更新日期/Last Update: 2021-03-10